Wednesday, September 17, 2025 9/17/2025

Statistical methods for interpretation of genetic variants by gene regulatory networks

Award Number: R35GM150513
ORGANIZATION: NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 09/08/2023
PERIOD OF PERFORMANCE END DATE: 08/31/2028

Group Awards By:

View Award Description

Statistical methods for interpretation of genetic variants by gene regulatory networks - Project Summary A person’s genome typically contains millions of variants which represent the differences between this personal genome and the reference human genome. Interpretation of how these variants cause diseases and understanding the mechanism(s) of their statistical associations to phenotype are crucial problems in computational biology and genetics. The problems are not straightforward to address because over 90% of disease-associated variants are in non-coding regions that have highly specific cellular context regulatory functions and about which we have limited comprehension. The long-term goal of this project is to explain mechanistically how non-coding genetic variants affect cellular context-dependent gene regulatory networks and influence phenotypes. Expression quantitative trait locus (eQTL) mapping and Gene regulatory networks (GRNs) are two common approaches for interpreting regulatory mechanisms of genetic variants. eQTL mapping connects variants in non-coding regions to genes by a population-based association study. GRNs provide information on the cis-regulatory elements that control context-specific expression of target genes, and information about the transcription factors that act on these elements. GRN-based variant interpretation is complementary to eQTL mapping and has the potential to overcome the limitations of eQTL mapping, which are: (1) eQTL mapping is biased for common alleles; (2) eQTL mapping cannot distinguish variants in strong linkage disequilibrium; and (3) the power to detect trans-eQTL is low. Most previous regulatory analysis research based on ENCODE data did not include personal genotyping data, and most eQTL mapping research did not include regulatory information. Joint modelling of eQTLs and GRNs would enable high-accuracy and mechanistic variant interpretation. However, the required dataset for such analysis - matched gene expression, epigenome, and genotyping data from the same individuals - are not available for a large human sample. Available datasets are cross-individual paired genotyping and gene expression data, such as GTEx data, and cross-cellular-contexts paired gene expression and epigenomics data, such as ENCODE data. These two types of paired data are also available at the single cell level. To achieve our long-term goal, we will develop statistical methods to integrate these unmatched datasets (either bulk or single cell) from different sources to (1) infer high accuracy context-specific GRNs to connect variants, transcription factors, cis-regulatory elements, and target genes; and (2) detect trans-eQTLs that regulate target genes. These methods can be extended to interpret disease-associated variants, identify causal variants, and infer personalized drug response to provide guidance for precision medicine. This project is fundamental for precision medicine, and it will increase our understanding of how genetic variants contribute to phenotype.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $605,210 )
2025	2025	TRUSTEES OF INDIANA UNIVERSITY	980 INDIANA AVE RM 2232	INDIANAPOLIS	IN	46202	MARION	USA	Biomedical Research and Research Training	002	4	8/12/2025	NON-COMPETING CONTINUATION	$359,402
2025	2025	TRUSTEES OF INDIANA UNIVERSITY	980 INDIANA AVE RM 2232	INDIANAPOLIS	IN	46202	MARION	USA	Biomedical Research and Research Training	003	4	8/12/2025	NON-COMPETING CONTINUATION	$359,402
2025	2024	CLEMSON UNIVERSITY	201 SIKES HALL	CLEMSON	SC	29634	PICKENS	USA	Biomedical Research and Research Training	000	2	6/30/2025	NON-COMPETING CONTINUATION	-$286,651
2025	2024	TRUSTEES OF INDIANA UNIVERSITY	980 INDIANA AVE RM 2232	INDIANAPOLIS	IN	46202	MARION	USA	Biomedical Research and Research Training	002	4	8/12/2025	NON-COMPETING CONTINUATION	-$69,376
2025	2024	TRUSTEES OF INDIANA UNIVERSITY	980 INDIANA AVE RM 2232	INDIANAPOLIS	IN	46202	MARION	USA	Biomedical Research and Research Training	001	3	7/1/2025	CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION	$242,433
														Subtotal = $605,210

Issue Date FY: 2024 ( Subtotal = $357,994 )
2024	2024	CLEMSON UNIVERSITY	201 SIKES HALL	CLEMSON	SC	29634	PICKENS	USA	Biomedical Research and Research Training	000	2	8/26/2024	NON-COMPETING CONTINUATION	$357,994
														Subtotal = $357,994

Issue Date FY: 2023 ( Subtotal = $355,853 )
2023	2023	CLEMSON UNIVERSITY	201 SIKES HALL	CLEMSON	SC	29634	PICKENS	USA	Biomedical Research and Research Training	000	1	9/8/2023	NEW	$355,853
														Subtotal = $355,853

Grand Total All Awards = $1,319,057

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Statistical methods for interpretation of genetic variants by gene regulatory networks

Award Number: R35GM150513

ORGANIZATION: NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 09/08/2023

PERIOD OF PERFORMANCE END DATE: 08/31/2028

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer